| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive Chairman | Director
5 companies
Marcus Joel S is a Director at Atara Biotherapeutics, Inc. with holdings across 5 companies. Recent SEC Form 4 filings include 2 buys and 1 sell.
Estimated insider holdings value: $43.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2018 | ATRA Atara Biotherapeutics, Inc. | Director | Sell | 10,000 | $36.35 | $363,500.00 | -56.9% | |
| Mar 10, 2015 | ATRA Atara Biotherapeutics, Inc. | Director | Buy | 4,000 | $29.57 | $118,285.00 | +160.0% |